David P. Schenkein, Chief Executive Officer at AGIOS PHARMACEUTICALS INC (AGIO), sold 47,144 shares at $80.35 ($3.8M) on 2018-01-26, disclosed to the SEC on 2018-01-30.
Open-market sale of $3.8M AGIO by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.35 | 9,237 | $742K | 19.4% |
| 2 | $80.35 | 9,237 | $742K | 19.4% |
| 3 | $81.40 | 11,369 | $925K | 24.2% |
| 4 | $81.40 | 11,369 | $925K | 24.2% |
| 5 | $82.22 | 2,966 | $244K | 6.4% |
| 6 | $82.22 | 2,966 |
| $244K |
| 6.4% |
| Total | $81.09 avg | 47,144 | $3.8M | 100% |
| Filing → |
| AGIO | SELL | 2024-02-27 | $4.5M | — | Filing → |
| AGIO | SELL | 2023-04-05 | $748K | — | Filing → |
| AGIO | SELL | 2023-03-29 | $443K | — | Filing → |